Report cover image

Indonesia IVD Market Analysis

Publisher Kalorama Information
Published Jul 19, 2017
Length 217 Pages
SKU # KLI15417339

Description

Indonesia IVD Market Analysis

Indonesia IVD Market Analysis provides market segmentation, discusses healthcare and regulatory trends, and examines in vitro diagnostics (IVD) manufacturers participating in Indonesia's marketplace. The following revenue information for 2017-2022 Indonesian IVD market segments is provided:
  • Rapid Tests for Infectious Diseases by Category (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Rapid Tests-Infectious Diseases, Total)
  • Microbiology (Rapid Tests-Infectious Diseases; Lab-based Immunoassays - Infectious Diseases; Molecular Diagnostics - Microbiology; Other [includes supplies, reagents, etc.]; Microbiology, Total)
  • Hematology (Hematology Systems; Hematology POC; Other [Digital imaging, analysis software, etc.]; Hematology, Total)
  • Clinical Chemistry (General Chemistry; Blood Gas Analyzers; Critical Care POC; Clinical Chemistry, Total)
  • Point of Care (POC-Diabetes; POC-OTC/Self-Testing, Other; POC-OTC/Self Testing, Total; Cardiac Markers; DOA/Toxicology; Other; POC-Professional, Total; POC, Total)
  • Immunoassays (Diabetes; Cardiac markers; Other [Cancer Markers, DOA tests; cholesterol, RIAs for thyroid, hormones, endocrine markers, etc.]; Total, Lab-based Immunoassays - Non-Infectious; DOA testing - rapid tests; Cancer markers - Rapid tests; Cardiac markers - Rapid tests; Others [Pregnancy, Cancer markers, etc.]; Total, POC - Immunoassays - Non-Infectious; Total – Immunoassays - Non-Infectious)
  • Blood Testing and Typing (ABO Grouping, Immunoassays [ELISA and Rapid Tests], NAT)
  • Hemostasis (Lab-based Coagulation Tests, POC Coagulation Tests)
  • Histology (Traditional Non-Pap Stains, Pap Tests, HPV, Other [includes ISH, IHC, Digital Imaging, CTC, and Flow Cytometry])
  • Major Diseases and Demand for Lab-based Immunoassay Diagnostics (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Lab-based Immunoassays - Infectious Diseases, Total)
  • Popular Rapid Test Brands and Their Distributors
  • Sexually Transmitted Disease (STD) Test Costs at Selected Clinics and Hospitals
  • Total IVD Market by Segment (Microbiology, Hematology, Clinical Chemistry, POC, Immunoassays - Non-Infectious Diseases, Blood Testing and Typing, Urinalysis, Coagulation, Histology, Others [includes Molecular Diagnostics (Non-Infectious), Supplies, Reagents, IT, Imaging, Automation, etc.])
Indonesia IVD Market Analysis notes trends influencing the opportunity and country-level information including incidence of disease, population demographics, economic status, healthcare utilization and other business influences. The report provides information regarding the total healthcare market in Indonesia, including: healthcare costs, 2000-2014 (total health expenditure as % of GDP, public health expenditure, private health expenditure); general and specialty hospitals, 2011-2015; community healthcare centers (CHCs), 2011-2015; distribution of puskesmas (CHCs) across the 34 provinces; and healthcare spending compared to Southeast Asia neighbors (New Zealand, Japan, Australia, South Korea, Vietnam, China, Singapore, India, Malaysia, Thailand).

As foreign IVD manufacturers are banned from making any direct sales in the Indonesia IVD market, options for multinational IVD concerns looking to enter the market are discussed. Three case studies are also provided.

In the report’s competitor analysis, profiles of those global manufacturers already participating in Indonesia’s IVD market, including Abbott Laboratories, Beckman Coulter, Bio-Rad, DiaSorin S.p.A., Hologic, Inc., Ortho Clinical Diagnostics, Roche Diagnostics, and Tosoh Corporation, are provided. The report provides as well information on private labs and distributors operating in the Indonesian IVD Market.

Market analysis in this report covers Indonesian markets for life science and clinical applications of in vitro diagnostics (IVD) technology. This Kalorama Information report was produced by Malaysia-based analysts and analysts operating in Indonesia.

Table of Contents

217 Pages
    • Introduction
    • Health Status of Indonesians
    • Healthcare Delivery System
    • Regulation of IVD Devices and Distribution
    • Scope and Methodology
    • Size and Growth of the IVD Market
    • Healthcare Expenditure
    • Health Indicators
    • Prevalent Infectious Diseases in Indonesia
    • Indonesian Healthcare Industry Landscape
    • Financial Aspects of the Healthcare Industry in Indonesia
    • E-Catalogue Pricing System
    • Key Market Drivers of the Indonesian Healthcare Market
    • Key Challenges in the Indonesian Healthcare Market
    • IVD Product Regulation in Indonesia
    • Important Factors to Consider While Choosing an IVD Distributor in Indonesia
    • Processes for Distribution License, Company and Product Registrations
    • Regulatory Trends and Insights Relevant for the IVD Sector
    • Regulations for Foreign Direct Investments (FDI)
    • Setting Up a Company in Indonesia
    • Business Strategies Adopted by Multinational Companies (MNCs): Case Studies
    • Microbiology
    • Hematology
    • Clinical Chemistry
    • Point-of-Care Tests
    • Immunoassays
    • Blood Testing and Typing
    • Urinalysis
    • Coagulation
    • Histology
    • Total IVD Markets in Indonesia
    • IVD Company Profiles
    • Leading Private Labs in Indonesia
    • Profiles of Selected IVD Distributors in Indonesia
    • Glossary

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us